Project Number 5R21AG033914-02 Agency/Funding Organization NIA Funding Year 2010 View Full Project Details for VALIDATION OF THE PGE2 EP4 RECEPTOR AS A THERAPEUTIC TARGET IN AD Research Categorization Primary Disease / Condition Alzheimer's Disease CADRO Category A. Molecular Pathogenesis and Physiology of Alzheimer's Disease and Alzheimer's Disease-related Dementias (AD/ADRDs) 9. Immunity and Inflammation d. Immunotherapy - Mechanisms of Action Researcher and Organization Principal Investigator ANDREASSON, KATRIN I Principal Investigator First Name KATRIN Principal Investigator Last Name ANDREASSON Awardee Organization STANFORD UNIVERSITY Awardee State California Contact PI Country United States Project Detail Funding Opportunity Announcement PAS-06-261: Grants for Alzheimer's Disease Drug Discovery (R21) FY Overall Cost $166,111 Funding Organization Agency/Funding Organization NIA Funding Organization Country United States Program Official REFOLO, LORENZO
